Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes

Nucleic Acids Research

Volumn 31, Issue 13, 2003, Pages 3850-3855

  Beerenwinkel, Niko ^f   Däumer, Martin ^a   Oette, Mark ^b   Korn, Klaus ^c   Hoffmann, Daniel ^d   Kaiser, Rolf ^a   Lengauer, Thomas ^f   Selbig, Joachim ^e   Walter, Hauke ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

^e MAX PLANCK INSTITUTE OF MOLECULAR PLANT PHYSIOLOGY   (Germany)

^f MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; STAVUDINE; TENOFOVIR DISOPROXIL; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CALCULATION; COMPLEX FORMATION; COMPUTER PREDICTION; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; GENE CONSTRUCT; GENE MUTATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; R FACTOR; REGRESSION ANALYSIS; SCORING SYSTEM; SEQUENCE ANALYSIS; STANDARDIZATION; STRUCTURAL GENE; SYSTEM ANALYSIS; UNINDEXED SEQUENCE; ANTIBIOTIC RESISTANCE; DNA SEQUENCE; DRUG EFFECT; FACTUAL DATABASE; GENETICS; INTERNET; METHODOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

ANTI-HIV AGENTS; DATABASES, FACTUAL; DRUG RESISTANCE, VIRAL; GENES, POL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INTERNET; PHENOTYPE; REGRESSION ANALYSIS; SEQUENCE ANALYSIS, DNA; SOFTWARE;

EID: 0043092351     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg575     Document Type: Article

References (15)

1. Shafer,R.W., Kantor,R. and Gonzales,M.J. (2000) The genetic basis of HIV-1 resistance to reverse transcriptase and protease inhibitors. AIDS Reviews, 2, 211-228.
2. Perrin,L. and Telenti,A. (1998) HIV treatment failure: testing for HIV resistance in clinical practice. Science, 280, 1871-1873.
3. Vandamme,A.M., Van Laethem,K. and De Clerq,E. (1999) Managing resistance to anti-HIV drugs: an important consideration for effective disease management. Drugs, 57, 337-361.
4. Walter,H., Schmidt,B., Korn,K., Vandamme,A.M., Harrer,T. and Überla,K. (1999) Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J. Clin. Virol., 13, 71-80.
5. DeGruttola,V., Dix,L., D'Aquila,R., Holder,D., Phillips,A., Ait-Khaled,M., Baxter,J., Clevenbergh,P., Hammer,S., Harrigan,R. et al. (2000) The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir. Ther., 5, 41-48.
6. Rhee,S.-Y., Gonzales,M.J., Kantor,R., Betts,B.J., Ravela,J. and Shafer,R.W. (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acid Res., 31, 298-303.
7. Sevin,A.D., DeGruttola,V., Nijhuis,M., Schapiro,J.M., Foulkes,A.S., Para,M.F. and Boucher,C.A. (2000) Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333. J. Infect. Dis., 182, 59-67.
8. Beerenwinkel,N., Schmidt,B., Walter,H., Kaiser,R., Lengauer,T., Hoffmann,D., Korn,K. and Selbig,J. (2001) Geno2pheno: Interpreting genotypic HIV drug resistance tests. IEEE Intellig. Syst., 16, 35-41.
9. Beerenwinkel,N., Schmidt,B., Walter,H., Kaiser,R., Lengauer,T., Hoffmann,D., Korn,K. and Selbig,J. (2002) Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc. Natl Acad. Sci. USA, 99, 8271-8276.
10. Vapnik,V. (1988) Statistical Learning Theory. Wiley, New York, NY.
11. Dempster,A., Laird,N. and Rubin,D. (1977) Maximum likelihood from incomplete data via the EM algorithm (with discussions). J. R. Statist. Soc. B., 39, 1-38.
12. Harrigan,P.R., Montaner,J.S.G., Wegner,S.A., Verbiest,W., Miller,V., Wood,R. and Larder,A.B. (2001) World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing. AIDS, 15, 1671-1677.
13. DiRienzo,G. and DeGruttola,V. (2002) Collaborative HIV resistance-response database initiatives: sample size for detection of relationships between HIV-1 genotype and HIV-1 RNA response using a non-parametric approach. Antivir Ther., 7, S71.
14. De Luca,A., Vendittoli,M., Baldini,F., Di Giambenedetto,S., Rizzo,M.G., Trotta,M.P., Cingolani,A., Forbici,F., Perno,C.F., Antinori,A. et al. (2002) Construction, training and clinical validation of an inferential interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules learning from virological outcomes. Antivir. Ther., 7, S71.
15. Beerenwinkel,N., Lengauer,T., Däumer,M., Kaiser,R., Walter,H., Korn,K., Hoffmann,D. and Selbig,J. (2003) Methods for optimizing antiviral combination therapies. Bioinformatics, 19 (Suppl. 1), i16-i25